The FDA granted zongertinib Breakthrough Therapy Designation for patients with HER2 (ERBB2)-mutant advanced NSCLC as an initial treatment. The FDA also awarded a Commissioner's National Priority ...
This press release is not intended for UK mediaHERNEXEOS® (zongertinib tablets) approved based on an objective response rate of 76% (N=72) as ...
Blueprint Medicines, a Sanofi company, today announced AYVAKIT(R) (avapritinib) data showing clinically meaningful outcomes and a w ...
This press release is not intended for UK media HERNEXEOS (zongertinib tablets) approved based on an objective response rate of 76% (N=72) as demonstrated in the Beamion LUNG-1 clinical trial1 Acceler ...
CRISPR gene drives bias inheritance in pests, advancing population-level control while raising questions about resistance and ...
If approved, Ojemda® (tovorafenib) is expected to be the first and only targeted medicine in European Union for children with ...
Early diagnosis of rare diseases in children can significantly improve treatment outcomes and quality of life. Learn symptoms, challenges, and why early detection is crucial for managing pediatric ...
A single exposure to a toxic fungicide during pregnancy can increase epigenetic disease risk for 20 subsequent generations.
While all cats are said to have nine lives, some breeds are naturally hardier than others. Breeds shaped by natural evolution ...
Figuring out who to screen could change the game. This discovery is getting us closer.
Victor Davis Hanson, a senior contributor for The Daily Signal, is a classicist and historian at the Hoover Institution at ...
The Canadian Paediatric Society is recommending cholesterol screening for all kids between two and 10 years old. The position statement released Friday says atherosclerosis — or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results